title: Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
abstract: In this study, we describe the properties of novel ETV1 fusion genes, encoding N-truncated ETV1 (dETV1), and of full-length ETV1, overexpressed in clinical prostate cancer. We detected overexpression of novel ETV1 fusion genes or of full-length ETV1 in 10% of prostate cancers. Novel ETV1 fusion partners included FOXP1, an EST (EST14), and an endogenous retroviral repeat sequence (HERVK17). Like TMPRSS2, EST14 and HERVK17 were prostate-specific and androgen-regulated expressed. This unique expression pattern of most ETV1 fusion partners seems an important determinant in prostate cancer development. In transient reporter assays, full-length ETV1 was a strong transactivator, whereas dETV1 was not. However, several of the biological properties of dETV1 and full-length ETV1 were identical. On stable overexpression, both induced migration and invasion of immortalized nontumorigenic PNT2C2 prostate epithelial cells. In contrast to dETV1, full-length ETV1 also induced anchorage-independent growth of these cells. PNT2C2 cells stably transfected with dETV1 or full-length ETV1 expression constructs showed small differences in induced expression of target genes. Many genes involved in tumor invasion/metastasis, including uPA/uPAR and MMPs, were up-regulated in both cell types. Integrin beta3 (ITGB3) was clearly up-regulated by full-length ETV1 but much less by dETV1. Based on the present data and on previous findings, a novel concept of the role of dETV1 and of full-length ETV1 overexpression in prostate cancer is proposed.
authors.affiliation: Department of Pathology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
authors.forename: Karin G
authors.initials: KG
authors.lastname: Hermans
authors.forename: Hetty A
authors.initials: HA
authors.lastname: van der Korput
authors.forename: Ronald
authors.initials: R
authors.lastname: van Marion
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: van de Wijngaart
authors.forename: Angelique
authors.initials: A
authors.lastname: Ziel-van der Made
authors.forename: Natasja F
authors.initials: NF
authors.lastname: Dits
authors.forename: Joost L
authors.initials: JL
authors.lastname: Boormans
authors.forename: Theo H
authors.initials: TH
authors.lastname: van der Kwast
authors.forename: Herman
authors.initials: H
authors.lastname: van Dekken
authors.forename: Chris H
authors.initials: CH
authors.lastname: Bangma
authors.forename: Hanneke
authors.initials: H
authors.lastname: Korsten
authors.forename: Robert
authors.initials: R
authors.lastname: Kraaij
authors.forename: Guido
authors.initials: G
authors.lastname: Jenster
authors.forename: Jan
authors.initials: J
authors.lastname: Trapman
mesh_terms: D000818:Animals; D002448:Cell Adhesion / Q000235:genetics; D002465:Cell Movement / Q000235:genetics; D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000235:genetics*; D020224:Expressed Sequence Tags; D051858:Forkhead Transcription Factors / Q000235:genetics; D015870:Gene Expression; D050939:Gene Fusion; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D012097:Repressor Proteins / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; C490641:Etv1 protein, mouse; D051858:Forkhead Transcription Factors; C432917:Foxp1 protein, mouse; D012333:RNA, Messenger; D012097:Repressor Proteins; D014157:Transcription Factors